Clover Health Investments
CLOV
137 hedge funds and large institutions have $1.21B invested in Clover Health Investments in 2021 Q1 according to their latest regulatory filings, with 93 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 49 closing their positions.
302% more capital invested
Capital invested by funds: $300M → $1.21B (+$907M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
89.88% more ownership
Funds ownership: 21.66% → 111.55% (+90%)
90% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 49
47% more funds holding
Funds holding: 93 → 137 (+44)
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
26% more call options, than puts
Call options by funds: $62.8M | Put options by funds: $49.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
Greenoaks Capital Partners
Orinda,
California
|
+$1.09B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$296M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$58M |
| 4 |
SIG
Senator Investment Group
New York
|
+$56.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$29.9M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$20.8M |
| 3 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$20.1M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$13.2M |
| 5 |
GC
Greenlight Capital
New York
|
-$11.7M |
CLOV Hedge Fund Activity: Q1 2021 in Review
137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q1 2021, worth a combined $1.21B — up 302% from $300M a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new CLOV positions and 49 closed out — a net gain of 44 holders — while 18 added to existing stakes and 13 trimmed.
The largest buyer was Greenoaks Capital Partners, opening a new position worth an estimated $1.09B. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $29.9M sold.
- 137 institutional investors held Clover Health Investments (CLOV) as of Q1 2021, up from 93 in Q4 2020.
- Funds reported $1.21B of Clover Health Investments stock for Q1 2021, up 302% quarter-over-quarter.
- 93 funds opened new Clover Health Investments positions in Q1 2021 and 49 closed out, a net change of +44 holders.
- The largest Clover Health Investments buyer in Q1 2021 was Greenoaks Capital Partners, an estimated $1.09B added.
- The largest Clover Health Investments seller in Q1 2021 was Alyeska Investment Group, an estimated $29.9M sold.
Based on aggregated 13F filings for Q1 2021.